会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS AND USES RELATING THERETO
    • 抗生素保护措施
    • WO2009115508A2
    • 2009-09-24
    • PCT/EP2009/053119
    • 2009-03-17
    • INTERCELL AGMEINKE, AndreasTEUBENBACHER, AstridSENN, BeatriceZERBS, ManuelHANNER, MarkusPIKALO, JuttaNAGY, EszterGIEFING, CarmenVON GABAIN, Alexander
    • MEINKE, AndreasTEUBENBACHER, AstridSENN, BeatriceZERBS, ManuelHANNER, MarkusPIKALO, JuttaNAGY, EszterGIEFING, CarmenVON GABAIN, Alexander
    • C07K14/315C07K16/12G01N33/68A61K39/09
    • A61K39/092C07K14/3156G01N33/56944G01N2333/3156G01N2469/20
    • The present invention relates to a protective peptide of Streptococcus pneumoniae (S. pneumoniae) or a functionally active variant of the protective peptide; a composition comprising at least two protective peptides or functionally active variants thereof; a composition comprising at least two proteins selected from the group consisting of i) a first type of protective peptide or functionally active variant thereof, ii) a second type of protective peptide or functionally active variant thereof and iii) a supportive peptide or a functionally active variant thereof; one or more nucleic acid(s) encoding the protective peptide or functionally active variant thereof or the at least two proteins comprised in the composition; a pharmaceutical composition comprising the protective peptide or functionally active variant thereof, the composition, or the nucleic acid(s); a method of producing an antibody using the protective peptide or functionally active variant thereof or the composition; the use of the protective peptide or functionally active variant thereof and/or the composition and/or the nucleic acid(s) for the manufacture of a medicament for the immunization or treatment of a subject; a method of diagnosing a S. pneumoniae infection using the protective peptide or a functionally active variant thereof, the composition or a primer and/or probe specific for the nucleic acid(s); a method for identifying a ligand capable of binding to a protective peptide or functionally active variant thereof; and the use of a protective peptide or functionally active variant thereof for the isolation and/or purification and/or identification of an interaction partner of the peptide.
    • 本发明涉及肺炎链球菌(Streptococcus pneumoniae)(肺炎链球菌)的保护肽或保护性肽的功能活性变体; 包含至少两种保护性肽或其功能活性变体的组合物; 包含至少两种选自i)第一类保护性肽或其功能活性变体的蛋白质的组合物,ii)第二类型的保护性肽或其功能活性变体,和iii)支持肽或功能活性 其变体; 一种或多种编码保护性肽或其功能活性变体的核酸或组合物中包含的至少两种蛋白质; 包含保护性肽或其功能活性变体,组合物或核酸的药物组合物; 使用保护性肽或其功能活性变体或组合物制备抗体的方法; 保护性肽或其功能活性变体和/或组合物和/或核酸在制备用于免疫或治疗受试者的药物中的用途; 使用保护性肽或其功能活性变体来诊断肺炎链球菌感染的方法,所述组合物或对所述核酸特异性的引物和/或探针; 用于鉴定能够结合保护性肽或其功能活性变体的配体的方法; 以及使用保护性肽或其功能活性变体来分离和/或纯化和/或鉴定肽的相互作用配偶体。
    • 2. 发明申请
    • PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS AND USES RELATING THERETO
    • 抗菌肽抗菌素及其组合物,方法和用途
    • WO2009115508A3
    • 2009-11-12
    • PCT/EP2009053119
    • 2009-03-17
    • INTERCELL AGMEINKE ANDREASTEUBENBACHER ASTRIDSENN BEATRICEZERBS MANUELHANNER MARKUSPIKALO JUTTANAGY ESZTERGIEFING CARMENVON GABAIN ALEXANDER
    • MEINKE ANDREASTEUBENBACHER ASTRIDSENN BEATRICEZERBS MANUELHANNER MARKUSPIKALO JUTTANAGY ESZTERGIEFING CARMENVON GABAIN ALEXANDER
    • C07K14/315A61K39/09C07K16/12G01N33/68
    • A61K39/092C07K14/3156G01N33/56944G01N2333/3156G01N2469/20
    • The present invention relates to a protective peptide of Streptococcus pneumoniae (S. pneumoniae) or a functionally active variant of the protective peptide; a composition comprising at least two protective peptides or functionally active variants thereof; a composition comprising at least two proteins selected from the group consisting of i) a first type of protective peptide or functionally active variant thereof, ii) a second type of protective peptide or functionally active variant thereof and iii) a supportive peptide or a functionally active variant thereof; one or more nucleic acid(s) encoding the protective peptide or functionally active variant thereof or the at least two proteins comprised in the composition; a pharmaceutical composition comprising the protective peptide or functionally active variant thereof, the composition, or the nucleic acid(s); a method of producing an antibody using the protective peptide or functionally active variant thereof or the composition; the use of the protective peptide or functionally active variant thereof and/or the composition and/or the nucleic acid(s) for the manufacture of a medicament for the immunization or treatment of a subject; a method of diagnosing a S. pneumoniae infection using the protective peptide or a functionally active variant thereof, the composition or a primer and/or probe specific for the nucleic acid(s); a method for identifying a ligand capable of binding to a protective peptide or functionally active variant thereof; and the use of a protective peptide or functionally active variant thereof for the isolation and/or purification and/or identification of an interaction partner of the peptide.
    • 本发明涉及肺炎链球菌(Streptococcus pneumoniae)(肺炎链球菌)的保护肽或保护性肽的功能活性变体; 包含至少两种保护性肽或其功能活性变体的组合物; 包含至少两种选自i)第一类保护性肽或其功能活性变体的蛋白质的组合物,ii)第二类型的保护性肽或其功能活性变体,和iii)支持肽或功能活性 其变体; 一种或多种编码保护性肽或其功能活性变体的核酸或组合物中包含的至少两种蛋白质; 包含保护性肽或其功能活性变体,组合物或核酸的药物组合物; 使用保护性肽或其功能活性变体或组合物制备抗体的方法; 保护性肽或其功能活性变体和/或组合物和/或核酸在制备用于免疫或治疗受试者的药物中的用途; 使用保护性肽或其功能活性变体来诊断肺炎链球菌感染的方法,所述组合物或对所述核酸特异性的引物和/或探针; 用于鉴定能够结合保护性肽或其功能活性变体的配体的方法; 以及使用保护性肽或其功能活性变体来分离和/或纯化和/或鉴定肽的相互作用配偶体。
    • 3. 发明申请
    • PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS AND USES RELATING THERETO
    • 抗菌肽抗菌素及其组合物,方法和用途
    • WO2008061953A1
    • 2008-05-29
    • PCT/EP2007/062493
    • 2007-11-19
    • INTERCELL AGNAGY, EszterGIEFING, CarmenVON GABAIN, AlexanderHANNER, MarkusPIKALO, JuttaSENN, BeatriceSCHUNN, MichaelSWATOSCH, GabrieleZERBS, Manuel
    • NAGY, EszterGIEFING, CarmenVON GABAIN, AlexanderHANNER, MarkusPIKALO, JuttaSENN, BeatriceSCHUNN, MichaelSWATOSCH, GabrieleZERBS, Manuel
    • A61K39/09C07K14/315G01N33/569
    • G01N33/56944G01N2469/20
    • The present invention relates to a protective peptide or a functionally active variant of the protective peptide; a composition comprising at least two proteins selected from the group consisting of i) a first type of protective peptide or functionally active variant thereof, ii) a second type of protective peptide or functionally active variant thereof and iii) a supportive peptide or a functionally active variant thereof; one or more nucleic acid(s) encoding the protective peptide or functionally active variant thereof or the at least two proteins comprised in the composition; a pharmaceutical composition comprising the protective peptide or functionally active variant thereof, the composition, or the nucleic acid(s); a method of producing an antibody using the protective peptide or functionally active variant thereof or the composition; the use of the protective peptide or functionally active variant thereof and/or the composition and/or the nucleic acid(s) for the manufacture of a medicament for the immunization or treatment of a subject; a method of diagnosing a S. pneumoniae infect ion using the protective peptide or a functionally active variant thereof, the composition or a primer and/or probe specific for the nucleic acid(s); a method for identifying a ligand capable of binding to a protective peptide or variant thereof; and the use of a protective peptide or variant thereof for the isolation and/or purification and/or identification of an interaction partner of the peptide.
    • 本发明涉及保护性肽或保护性肽的功能活性变体; 包含至少两种选自i)第一类保护性肽或其功能活性变体的蛋白质的组合物,ii)第二类型的保护性肽或其功能活性变体,和iii)支持肽或功能活性 其变体; 一种或多种编码保护性肽或其功能活性变体的核酸或组合物中包含的至少两种蛋白质; 包含保护性肽或其功能活性变体,组合物或核酸的药物组合物; 使用保护性肽或其功能活性变体或组合物制备抗体的方法; 保护性肽或其功能活性变体和/或组合物和/或核酸在制备用于免疫或治疗受试者的药物中的用途; 使用保护性肽或其功能活性变体诊断肺炎链球菌感染的方法,所述组合物或对核酸特异性的引物和/或探针; 用于鉴定能够结合保护性肽或其变体的配体的方法; 以及使用保护性肽或其变体来分离和/或纯化和/或鉴定该肽的相互作用配偶体。